AMO Pharma
PrivateLast Round
Private Equity
Dec 6, 2022
Total Funding Raised
$25M
Company Overview
AMO Pharma operates in Healthcare & Life Sciences and is based in Leeds. Its latest recorded funding round was a Private Equity round in December 2022.
AMO Pharma is a biopharmaceutical company that develops treatments for serious and debilitating rare genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMO Pharma Comparables
Compare AMO Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuren Pharmaceuticals Limited | 80% | |
| Novartis | 78% | |
| Connecta Therapeutics | 78% |
For institutional investors. Book with your work email.
AMO Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Dec 6, 2022 | ||||
| Private Equity | May 10, 2022 | ||||
| VC Round | Jan 9, 2020 | ||||
| Private Equity | Sep 30, 2015 |
For institutional investors. Book with your work email.
AMO Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Woodford Investment Management | Private Equity |
| Schroders | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 39% MoM to 5.2K.
- Jun 1, 2025
Monthly visitors increased 90% MoM.
For institutional investors. Book with your work email.
AMO Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AMO Pharma's valuation, stock price, and market status.
Is AMO Pharma a public or private company?
AMO Pharma is a private company.
What is the current stock price of AMO Pharma?
AMO Pharma is a private company, so its shares have no public market price. Caplight tracks AMO Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AMO Pharma worth (valuation)?
Valuation information for AMO Pharma is not publicly available.
Can I buy AMO Pharma stock?
AMO Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AMO Pharma's last funding round?
AMO Pharma's most recent funding round was Private Equity on December 6, 2022.
Who are the main investors in AMO Pharma?
Key investors in AMO Pharma include Woodford Investment Management.
Will AMO Pharma IPO soon?
No public IPO plans have been announced for AMO Pharma.
How can I track AMO Pharma secondary market activity?
Caplight tracks bids, offers, and trades in AMO Pharma's shares on secondary markets.